Skip to main content

Tweets

Friday's podcast "You Can Have it All” is out now and available for download. Dr. Jack Cush reviews the news and highlights from our "Women in Rheumatology" Campaign from last week on RheumNow. https://t.co/ugZNDqfvsB https://t.co/kNkVwIAlJ5
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
2022 Doximity Physician salary survey shows that among the least paid specialties; Pediatric rheumatology was #3 at $226k and Adult Rheumatology was #20 at $299K https://t.co/HL7vReY6Vg https://t.co/LbWQ9IBUWr
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
Did you miss this week’s TNR? Check it now. Straddling Career and Family https://t.co/gFknaiJZBa https://t.co/K5VhxVeW1y
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
What Advocacy Taught Me About Leadership https://t.co/biwd8ueSI0 https://t.co/ZDizyGHttO
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
British Society of Rheumatology Plans Revision of Systemic Sclerosis Guideline BSR last published its guideline for SSc in 2016. Given the many advances in the field the BSR has outlined their plans to update the management of SSc. https://t.co/s4AKdVS2H7 https://t.co/MmIGw2QLEn
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
Inflammasome inhibitors in development: - RRx-001 in cancer, ALS, parkinsons - OLT1177 in OA knee, gout, Schnitzlers - DFV890 in CAPs, knee OA - IZD174/334 in CAPS - ZYIL1 CAPS https://t.co/1oCmKIHchP https://t.co/Y8CBAx2T7w
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
New downlaod available: Gender Risk in Rheumatic Disease https://t.co/5AQhSNzrvh https://t.co/wTGnCk7ctj
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
EMA Final Update on JAK Inhibitors and MACE, Malignancy & VTE Risks https://t.co/k4UZZtyvdf https://t.co/ZI3NMw7Iec
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
Paxlovid (Nirmatrelvir-Ritonavir) should be used w/in 5d of COVID Sxs onset. Drug interactions include: steroids, anticoagulants (Eliquis, Xarelto, warfarin), Flomax, Calcium channel blockers, benzodiazepines. https://t.co/FmjeWvWo58 https://t.co/BaKwun23pD
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
Frunevetmab (Solensia), is a cat-specific mAb against nerve growth factor was FDA approved, for use in CATS, to treat the pain of osteoarthritis. CATS! https://t.co/OFb0vtndf1 https://t.co/14g2Fzeh2i
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
DESIR - early SpA Cohort study of 494 pts (half F); w/ 6 yrs F/U, Women had higher ASDAS-CRP & PtGA (P < 0.0001; vs men), yet CRP was similar and structural damage more frequent in men (P < 0.0001). https://t.co/cxehQuEOtu https://t.co/6PwtjEgLDD
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
RheumThoughts: Changing the Conversation with Patients: Lupus https://t.co/rFM2211Toq https://t.co/I9yWGMCH9B
Dr. John Cush @RheumNow ( View Tweet )
3 years 3 months ago
×